• Latest Posts

Boehringer Ingelheim Enters the Clinic with Two New Diabetes Drugs

Danish Diabetes Biotech Rakes in $75M on NASDAQ in American IPO

Danish Diabetes Biotech Shoots for a €75M IPO in the US Nasdaq

New Combo Therapy for Type 2 Diabetes to Sweep Europe

Could this be the ‘Beginning of the end’ for Diabetes? Let’s Review.

Here are 12 Biotechs you need to know in Copenhagen – Skål!


Biotech of the Week: Zealand Pharma, Biotech Success Story made in Denmark

Money Money Money for Immuno-Oncology: BMS Joins up with a Top German VC

Giving new life to Sanofi’s annual €6.2Bn diabetes blockbuster Lantus